Recruiting
Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC
NCT04342910
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
- Locations
-
- Affiliated Hospital, Academy of Military Medical Sciences Beijing, China